Neumora Therapeutics Stock Forecast

Sell candidate since Jun 12, 2026 Loss -9.55%

The Neumora Therapeutics, Inc. stock price gained 5.23% on the last trading day (Tuesday, 23rd Jun 2026), rising from $1.53 to $1.61. During the last trading day the stock fluctuated 10.74% from a day low at $1.49 to a day high of $1.65. The price has risen in 5 of the last 10 days but is still down by -0.62% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 517 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $3.29 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -28.38% during the next 3 months and, with a 90% probability hold a price between $0.609 and $1.44 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

NMRA Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, June 15, 2026, and so far it has risen 76.05%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Neumora Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.78. On a fall, the stock will find some support from the short-term average at $1.49. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Neumora Therapeutics, Inc. stock

Neumora Therapeutics, Inc. finds support from accumulated volume at $1.56 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.160 between high and low, or 10.74%. For the last week, the stock has had daily average volatility of 25.04%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NMRA) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Neumora Therapeutics, Inc. to open at $1.58, and during the day (based on 14 day Average True Range), to move between $1.50 and $1.72, which gives a possible trading interval of +/-$0.217 (+/-14.42%) up or down from last closing price. If Neumora Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 14.42% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.56 (3.11%) than the resistance at $1.78 (10.56%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Neumora Therapeutics, Inc. stock A Buy?

Neumora Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -2.663 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $1.58 ( 1.66%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk